Back to first-pass browser

First-pass extracted concept

IGFBP-6

Candidate: concept label1 source documents5 linked claims
Jump to explainersJump to evidenceJump to sourcesJump to claims
Live refresh every 5sNext refresh in 5s

Aliases

Insulin Growth Factor Binding Protein-6, Insulin-like growth factor binding protein-6

Extracted Explainers

What the tool is doing

The abstract describes IGFBP-6 as a high-affinity, IGF-II-preferring binding protein that modulates IGF bioavailability and cell signaling, including IGF-independent actions.

Source 1DOIPubMed

What problem it solves

The review frames IGFBP-6 as a potentially useful lever for diagnosis, patient stratification, and therapeutic targeting in liver disease.

Source 1DOIPubMed

Evidence Snippets

IGFBP-6, a high-affinity, IGF-II-preferring binding protein, has emerged as a context-dependent modulator of IGF bioavailability and cell signaling with additional IGF-independent actions.
Evidence 1Source 1DOIPubMedprovenance

Supporting Sources

Linked Claims

Claim 1cancer context activitymixed2026Source 1DOIPubMed

In primary liver cancers, IGFBP-6 has reported tumor-suppressive versus pro-migratory activities and potential crosstalk with hypoxia, Wnt/β-catenin, and TGF-β signaling and the tumor immune microenvironment.

Quoted textsource-backed
Finally, we examine IGFBP-6 in primary liver cancers-hepatocellular carcinoma and cholangiocarcinoma-highlighting evidence for tumor-suppressive versus pro-migratory activities, potential crosstalk with hypoxia, Wnt/β-catenin and TGF-β signaling, and interactions with the tumor immune microenvironment.
Claim 2disease associationsupports2026Source 1DOIPubMed

Experimental and clinical data link IGFBP-6 to steatotic liver disease, inflammation, and fibrogenesis.

Quoted textsource-backed
We then evaluate experimental and clinical data linking IGFBP-6 to steatotic liver disease, inflammation, and fibrogenesis, including putative roles in hepatocyte stress responses, stellate cell activation, and extracellular matrix remodeling.
Claim 3molecular functionsupports2026Source 1DOIPubMed

IGFBP-6 is a high-affinity IGF-II-preferring binding protein that modulates IGF bioavailability and cell signaling and also has IGF-independent actions.

Quoted textsource-backed
IGFBP-6, a high-affinity, IGF-II-preferring binding protein, has emerged as a context-dependent modulator of IGF bioavailability and cell signaling with additional IGF-independent actions.
Claim 4pathway associationsupports2026Source 1DOIPubMed

IGFBP-6 affects canonical IGF-II/IGF1R signaling and downstream PI3K-AKT and RAS-MAPK pathways in liver biology contexts.

Quoted textsource-backed
We first outline hepatic expression, regulation, and post-translational processing of IGFBP-6 across development, homeostasis, and injury, and summarize its effects on canonical IGF-II/IGF1R signaling and downstream phosphatidylinositol 3-kinase-protein kinase B (PI3K-AKT) and rat sarcoma-mitogen-activated protein kinase (RAS-MAPK) pathways.
Claim 5translational potentialsupports2026Source 1DOIPubMed

IGFBP-6 has translational potential as a circulating or tissue biomarker, for patient stratification, and as a therapeutic target in liver disease.

Quoted textsource-backed
Across conditions, we assess the translational potential of IGFBP-6 as a circulating or tissue biomarker, its utility for patient stratification, and prospects for therapeutic targeting-either by modulating IGF-II sequestration or exploiting IGF-independent mechanisms.